As Agentic AI Gains Traction, 86% of Enterprises Anticipate Heightened Risks, Yet Only 2% of Companies Meet Responsible AI Gold Standards
With 95% of enterprises facing incidents, Infosys research reveals wide gap between…
American Financial Group, Inc. Announces Second Quarter Results
Net earnings per share of $2.07; includes $0.07 per share loss from…
TrimIQ Weight Loss: Official launched in UK and Ireland With Green Tea Probiotic Complex
New York City, NY, Aug. 02, 2025 (GLOBE NEWSWIRE) -- TrimIQ UK,…
PMI Calls for Ongoing G2G Dialogues with Source and Transit Countries to Combat Illicit Tobacco Trade
- India faces an annual loss of approximately $1.65 billion, with 25%…
Pink Salt Trick Recipe to Weight Loss Trend 2025: An Analysis of Slumber Slim as a Science Informed Option
Albany, New York, July 26, 2025 (GLOBE NEWSWIRE) -- An internet-viral pink…
Justice4Heroes Campaign Demands Equality in Military Hearing Loss Compensation
Monday 21 July, 2025 PRESS RELEASE FOR IMMEDIATE RELEASE Justice4Heroes Campaign Demands…
Safest SARMs For Muscle Growth 2025: CrazyBulk IntroducesEffectiveSARMs For Bulking, Cutting and Strength in USA.
Albany, New York, July 15, 2025 (GLOBE NEWSWIRE) -- In the ever-evolving…
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed…
Novo Nordisk: Higher dose of Wegovy provided average weight loss of 21% in people with obesity with a third achieving 25% or more according to data presented at ADA
Higher dose of Wegovy® provided average weight loss of 21% in people…
Novo Nordisks subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025
Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss…